Connex 3
Research payments
$2,283,881
Through program year 2023, $2,283,881 in research payments was reported against Connex 3, across 136 payments.
- Paid by (largest first)
- Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim RCV GmbH & Co KG; Boehringer Ingelheim International GmbH
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $1,162,448 | 73 |
| 2022 | Research | $1,052,744 | 55 |
| 2021 | Research | $68,689 | 8 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Austina Cho Anaheim, CA Named on 7 payments
- Bethany Davis Atlanta, GA Named on 7 payments
- Richard Sanders Moraine, OH Named on 6 payments
- George Konis North Little Rock, AR Named on 6 payments
- Lars Jarskog Chapel Hill, NC Named on 5 payments
- Stephen Marder Los Angeles, CA Named on 5 payments
- Marvin Peyton Oklahoma City, OK Named on 5 payments
- Steven Glass Marlton, NJ Named on 5 payments
- Marina Bussel Culver City, CA Named on 5 payments
- Aliuska Alvarez Miami, FL Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.